微生物来源的Hsp90抑制剂国内外研发情况及市场分析
摘要
Hsp90 is a molecular chaperone, exists in normal cells as a monomer. In tumor cells,Hsp90 combined with effect proteins of tumor cells as multi-chaperone complex. Hsp90 inhibitors from microbiology are increasingly concerned by people and some of the compounds had entered the stage of clinical trials. Finding and developing Hsp90 inhibitors had become a hotspot. The R & D and market of Hsp90 inhibitor was analyzed at home and abroad, hoped to play a guiding role for clinical medicine, enterprises and make production tactics.
引用本文（GB/T 7714）
Sai-di He, Juefen Gu. 微生物来源的Hsp90抑制剂国内外研发情况及市场分析[J]. 国际药学研究, 2014.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。